June 17, 2016 / 12:23 PM / in a year

BRIEF-Valeant pharmaceuticals says invests in Canadian operations

June 17 (Reuters) - Valeant Pharmaceuticals International Inc

* Valeant Pharmaceuticals announces significant investments in Canadian operations

* $12.5 million investment in Laval, Quebec facility and transfer of Arestin  production

* $15 million investment in Steinbach, Manitoba facility and transfer of Xifaxan  and Apriso  production

* Valeant Canada expanding Canadian manufacturing, export capacity with investments totaling $27.5 million

* $15 million investment includes $7 million in upgrades to product manufacturing technology

* $15 million investment also includes $8 million for transfer of North American production of Xifaxan (rifaximin) and Apriso Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below